Halda Therapeutics

Drug Discovery · New Haven, CT · Founded 2018 · Privately Held (backing)

Developer of a drug discovery platform designed to create therapeutic and precision medicines. Halda Therapeutics is based in New Haven, CT and was founded in 2018. Its last known valuation is $3 billion. It has raised $227 million across 3 recorded rounds; the latest was a $126 million Series B in Jul 2024.

Last price · $/share
—
Implied valuation
$3.0B
Total raised
$227.1M
Last round
Later Stage VC (Series B)
Jul 2024
Cap table — not yet on record

Halda Therapeutics's share-class structure hasn't surfaced in our sources yet. Cap tables are assembled from certificates of incorporation, round filings, and disclosures as they land.

Pro members can request priority coverage with a 48-hour turnaround.
Free account
More of Halda Therapeutics with a free account
  • ·The complete investor list: 14 names
  • ·Watch Halda Therapeutics: the Monday email on marks, rounds and moves
Create free account
No card required

Membership and data by Private Market View

Frequently asked about Halda Therapeutics

Where does Halda Therapeutics's cap table come from?
Share classes are assembled from certificates of incorporation, priced-round filings, and disclosures across Halda Therapeutics's 3 recorded funding rounds.